retatrutide phase 2 obesity trial VisualAbstract: reduces body weight by 17.5% in patients with retatrutide phase 2 nejm weight

Thank you for your patience and understanding as we continue to keep the WNBF Truly Natural and competitive Worldwide

By targeting these pathways, Zepbound not only helps control appetite and slow gastric emptying but also improves blood sugar regulation

Oct 2024: A multi-society guidance (ASA, AGA, ASMBS, SAGES, etc.) concluded most patients can continue GLP-1s before elective surgery/endoscopy, with risk-stratified adjustments like liquid diet day prior, point-of-care gastric ultrasound, or brief hold for high-risk situations like active GI symptoms or rapid dose escalation

GLP-1 receptor activation reduces appetite, slows gastric emptying, and improves insulin secretion